Dual ICP: Assessing the Accuracy and the Impact of Standard-practice Ventricular Drainage on Intracranial Pressure Measurements Following Traumatic Brain Injury

Sponsor
University of Maryland, Baltimore (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02911675
Collaborator
United States Air Force (U.S. Fed)
0
1.8

Study Details

Study Description

Brief Summary

Traumatic brain injury (TBI) is a leading cause of death following injury in civilian populations and is a major cause of death and disability in combat casualties. While primary brain injury cannot be reversed, the management of severe TBI focuses on the mitigation of secondary injury mechanisms which occur as part of the downstream effects of the primary damage to the brain. Many secondary injury mechanisms are manifested clinically as elevated intracranial pressure (ICP) and cerebral perfusion pressure (CCP). This level and duration of elevated ICP is strongly associated with poor long term patient outcome.

Currently, there are two invasive techniques that are used at our facility for monitoring ICP and CPP. The first method requires the placement of an intra-parenchymal fiberoptic pressure monitor (IPM), also known as a camino, into the brain tissue that measures and displays ICP continuously. The second method requires placement of an extracranial ventricular drain (EVD) which both measures ICP when it is closed or clamped and also allows for therapeutic drainage of cerebral spinal fluid (CFS) to reduce pressure within the skull when it is open.

While clinical practices vary greatly across institutions, current clinical practice at our institution when using the EVD for ICP management is to allow continuous therapeutic CSF drainage and to manually close the drain for ICP assessment on an hourly basis. However, in a retrospective of study of TBI patients at our institution with simultaneous IPM and EVD placement, a spike in ICP was noted to correspond with the clamping of the EVD which often remained elevated for 15-30 minutes before returning to baseline. Due to the strong association between poor patient outcome and elevated ICP, this finding is alarming. These findings have important implications for procedures to not only treat elevated ICP, but also prevent potentially harmful intermittent elevations in ICP. Therefore, this study seeks to prospectively investigate the association between EVD clamping and elevated ICP.

Specifically, this study has 2 main objectives:
  1. Evaluate the need for an optimized device that can simultaneously measure intracranial pressure and drain CSF without requiring potentially harmful clamping.

  2. Provide data in support of retaining or modifying current clinical practices regarding intermittent versus continuous monitoring during periods of therapeutic drainage of CSF.

Condition or Disease Intervention/Treatment Phase
  • Device: EVD/IVC and the IPM/Camino

Detailed Description

Investigators plan a single-center, 36 month prospective observational study of 50 patients presenting with moderate to severe traumatic brain injury (TBI) at R Adams Cowley Shock Trauma Center who require intracranial pressure monitoring. This is an interventional device study utilizing the EVD/IVC and the IPM/Camino to provide and evaluate data for optimized treatment for the control of elevated ICP and CCP in patients with severe TBI. Enrolled patients will be randomized to one of two study groups listed below following the consent process. Once a potential participant has consented to the study, we will use the excel random number generator function (randbetween(0,1)) to generate random numbers between 0 and 1 for each participant. If 0 is generated participants will be placed in Group 1 (Hourly EVD closures) and if 1 is generated, participants will be placed in Group 2 (EVD closure every 12 hours). There is no placebo or control group.

Standard of Care (25 patients): Standard EVD management with therapeutic drainage as appropriate and hourly EVD ICP measurements with simultaneous IPM/Camino ICP measurements collected.

Experimental (25 patients): Therapeutic CSF drainage as appropriate, with EVD closure and ICP assessment every 12 hours with simultaneous IPM/Camino ICP measurements collected.

Data will be collected on age, mechanism of injury, time interval between injury and MRI, past medical history, admission hemodynamics, admission component GCS, post-resuscitation component GCS, injury severity score, abbreviated injury score for head injury, blunt carotid or vertebral artery injury, and therapeutic interventions. Continuous vital signs streams will be collected.

In addition, if available, video surveillance from the patient's stay in the Neurotrauma Critical Care Unit will be collected and be stored with the patients study data.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
0 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessing the Accuracy and the Impact of Standard-practice Ventricular Drainage on Intracranial Pressure Measurements Following Traumatic Brain Injury
Actual Study Start Date :
Dec 1, 2018
Actual Primary Completion Date :
Jan 24, 2019
Actual Study Completion Date :
Jan 24, 2019

Arms and Interventions

Arm Intervention/Treatment
Standard of Care Group

Study Group 1: Standard EVD/IVC management with therapeutic CSF drainage as appropriate and hourly EVD/IVC ICP measurements per standard of care with simultaneous IPM/Camino ICP measurements collected.

Device: EVD/IVC and the IPM/Camino
This is an interventional device study utilizing the EVD/IVC and the IPM/Camino to provide and evaluate data for optimized treatment for the control of elevated ICP and CCP in patients with severe TBI.

Experimental Group

Study Group 2: Therapeutic CSF drainage as appropriate, with EVD/IVC closure and ICP assessment approximately every 12 hours with simultaneous IPM/Camino ICP measurements collected.

Device: EVD/IVC and the IPM/Camino
This is an interventional device study utilizing the EVD/IVC and the IPM/Camino to provide and evaluate data for optimized treatment for the control of elevated ICP and CCP in patients with severe TBI.

Outcome Measures

Primary Outcome Measures

  1. Evaluate the need for an optimized device that can simultaneously measure intracranial pressure and drain CSF without requiring potentially harmful clamping. [6 months]

    Investigators want to find a better device that can measure pressure in the head after a traumatic brain without causing an increase in pressure inside of the head.

Secondary Outcome Measures

  1. Compare clinical practices regarding intermittent versus continuous monitoring during periods of therapeutic drainage of CSF. [6 months]

    Compare the current method of clamping the drain with the experimental method to determine if clamping the drain less will provide an accurate measure of pressure inside of the head.

Other Outcome Measures

  1. Evaluate the impact of the frequency of EVD drain closure on short and long (6 month) term functional outcomes. [6 months]

    Assess the impact of the frequency of EVD drain closure on short and long (6 month) term functional outcomes.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Direct trauma admission to STC by ambulance or helicopter

  • 18 years and older

  • Neurosurgical evaluation indicates placement of a EVD

  • Diagnosis of severe traumatic brain injury (head AIS > 2) and post-resuscitation motor CGS<6

Exclusion Criteria:
  • < 18 years of age

  • Non-survivable brain injury

  • Non-survivable anatomic injury

  • Pregnancy

  • Non-English speaker

  • Prisoner

  • Active duty military

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Maryland, Baltimore
  • United States Air Force

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Deborah Stein, Medical Director, Neurotrauma Critical Care; Chief, Section of Trauma Critical Care, R Adams Cowley Shock Trauma Center, University of Maryland, Baltimore
ClinicalTrials.gov Identifier:
NCT02911675
Other Study ID Numbers:
  • HP-00064113
First Posted:
Sep 22, 2016
Last Update Posted:
Jan 18, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 18, 2022